AptamiR Therapeutics, Inc.

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
AptamiR Therapeutics, Inc. is a biotechnology company focused on developing revolutionary treatments for human obesity and related metabolic disorders. Based on an innovative strategy targeting subcutaneous fat cells rather than the central nervous system or the intestinal absorption of food, AptamiR has designed microRNA-targeted therapeutics that enhance lipid oxidation, mitochondrial activity and thermogenesis, turning fat-storing white adipocytes into fat-burning adipocytes (brown-like, brite or beige).
MicroRNAs are attractive drug targets for complex diseases like diabesity and NAFLD, as they simultaneously modulate the expression of several genes.
Significant improvements in body weight, glucose control, insulin sensitivity, cholesterol and liver steatosis are achieved by AptamiR’s drug candidates.
AptamiR is also developing drug delivery systems that can specifically target human adipocytes and hepatocytes for various therapeutic loads.
AptamiR is now seeking to raise tranc
Ticker:
Not Provided
Exchange:
Not Provided
Company Type:
Not Provided
Company Website:
Company HQ State:
Florida
Company HQ Country:
United States
Year Founded:
2012
Main Therapeutic Focus:
Lead Product in Development:
miR-22 Antagomirs
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Two
Speaker
photo
Founder & President
AptamiR Therapeutics, Inc.